|
[1]
|
严晓伟, 陈红, 高炜, 等. 中华医学会心血管病学分会专家组对于美国心脏学会和美国心脏协会2013年血胆固醇治疗指南的共识性观点[J]. 中华心血管病杂志, 2014, 42(4): 275-276.
|
|
[2]
|
中华医学会心血管病学分会介入心脏病学组. 中国经皮冠状动脉介入治疗指南(2016) [J]. 中华心血管病杂志, 2016, 44(5): 382-400.
|
|
[3]
|
李瑶, 姚思宇, 石亚君, 等. 高血压合并冠心病患者血压负荷与冠脉病变严重程度的关系研究[J]. 中国分子心脏病学杂志, 2017(4): 2144-2146.
|
|
[4]
|
Ferrières, J. (2016) European Society of Cardiology Guidelines for the Management of Dyslipidemias. Presse Medicale, 46, 688-696. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
陈晓平, 崔兆强, 林金秀, 卢新政, 李悦, 李玉明, 李建平, 孙仰仰, 刘志浩, 刘梦苑. 《2020国际高血压学会全球高血压实践指南》解读[J]. 中国医学前沿杂志(电子版), 2020, 12(5): 54-60.
|
|
[6]
|
王洋, 龚燕平. 2019年ESC联合EASD对糖尿病前期、糖尿病、心血管疾病指南的解读[J]. 中国循证心血管医学杂志, 2020, 12(5): 516-518.
|
|
[7]
|
何权瀛, 高莹慧. 关于吸烟问题若干名词定义[J]. 中华结核和呼吸杂志, 2009(1): 26.
|
|
[8]
|
Williams, B., Mancia, G., Spiering, W., et al. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of Hypertension, 36, 1953-2041. [Google Scholar] [CrossRef]
|
|
[9]
|
Gensini, G.G. (1983) A More Meaningful Scoring System for Determining the Severity of Coronary Heart Disease. American Journal of Cardiology, 51, 606. [Google Scholar] [CrossRef]
|
|
[10]
|
None (2014) Comments on the ESC Guidelines on Diabetes, Prediabetes, and Cardiovascular Diseases Developed in Collaboration with the European Society for the Study of Diabetes. Revista Espaola De Cardiología, 67, 87-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Nicholls, S.J. and Nelson, A.J. (2019) Rivaroxaban with or without Aspirin for the Secondary Prevention of Cardiovascular Disease: Clinical Implications of the COMPASS Trial. American Journal of Cardiovascular Drugs, 19, 343-348.
|
|
[12]
|
姚朝阳, 田华伟, 梁爱敏. 高密度脂蛋白胆固醇与冠状动脉狭窄程度的相关性研究[J]. 中国循证心血管医学杂志, 2018(1): 91-94.
|
|
[13]
|
Brown, W.V., Remaley, A.T. and Ridker, P.M. (2015) JCL Roundtable: Is Inflammation a Future Target in Preventing Arteriosclerotic Cardiovascular Disease. Journal of Clinical Lipidology, 9, 119-128. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
潘志然, 于海初, 葛均华, 等. 血尿酸水平对冠状动脉狭窄程度的评价价值[J]. 精准医学杂志, 2018, 33(3): 267-269, 273.
|
|
[15]
|
Tuteja, S. and Rader, D.J. (2014) High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm. Clinical Pharmacology & Therapeutics, 96, 48-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Namazi, N., Larijani, B. and Azadbakht, L. (2018) Dietary Inflammatory Index and Its Association with the Risk of Cardiovascular Diseases, Metabolic Syndrome, and Mortality: A Systematic Review and Meta-Analysis. Hormone & Metabolic Research, 50, 345-358. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Numasawa, Y., Kohsaka, S., Miyata, H., et al. (2015) Impact of Body Mass Index on In-Hospital Complications in Patients Undergoing Percutaneous Coronary Intervention in a Japanese Real-World Multicenter Registry. PLoS ONE, 10, e0124399. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Yang, C.S., Wang, H. and Sheridan, Z.P. (2018) Studies on Prevention of Obesity, Metabolic Syndrome, Diabetes, Cardiovascular Diseases and Cancer by Tea. Journal of Food & Drug Analysis, 26, 1-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
吴蕊, 杨志明. 冠心病介入治疗后再狭窄危险因素的Meta分析[J]. 中西医结合心脑血管病杂志, 2009, 7(4): 477- 478.
|
|
[20]
|
吴珺, 吴蕊, 王昆, 等. 229例2型糖尿病患者出院后自我管理随访调查[J]. 山西医药杂志, 2016, 45(5): 523-526.
|